Phase 1b trial of BXQ 350.

Trial Profile

Phase 1b trial of BXQ 350.

Phase of Trial: Phase I

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Saposin C (Primary)
  • Indications Glioma; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Sep 2017 New trial record
    • 06 Sep 2017 According to a Bexion Pharmaceuticals media release, the highest dose tested in phase 1a trial will be used in this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top